Development of a Microfluidic Point-of-Care HCV Viral Load Assay
Award amount
$1,199,326Program and phase
SBIR · Phase IIAward year
2015Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- DAKTARI DIAGNOSTICS, INC.
- Proposal award date
- 2015-02-10
- Contract end date
- 2017-01-31
- UEI
- RCJGQUV3YTD5
- Solicitation number
- PA12-090
- Topic code
- R
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Highly sensitive zika and dengue antigen antibody combo test for the point of care
- Innovative concept for detection and identification of biological toxins
- An HIV Viral Load Assay for the Point Of Care
- Self-assembling density gradients for sickle cell diagnosis in low resource areas
- Development of a Microfluidic Point-of-Care HCV Viral Load Assay
Research funding history
6 SBIR/STTR records share this UEI (2014–2017). Reported award amounts total $2,820,594. Reported amounts are not federal obligations.
Phases: Phase I, Phase II – Direct to Phase II, Phase II
Agencies: Department of Health and Human Services, Department of Defense